Pancreatic polypeptide in islet cell tumors morphologic and functional correlations

Publisher Website
Google Scholar
Abstract
Twelve islet cell tumors and one islet cell hyperplasia were studied with immunocytochemical and radioimmunoassay methods. With immunocytochemical staining, all six insulinomas, one mixed insulinoma–glucagonoma, and four gastrinomas were positive for insulin, insulin and glucagon, and gastrin, respectively. Pancreatic polypeptide (PP) was positive in three insulinomas and one mixed insulinoma–glucagonoma. All of the tumors were positive for neuron‐specific enolase (NSE). Radioimmunoassays of tissue extracts further disclosed that all functioning tumors contained more than one pancreatic hormone. PP concentrations of two insulinomas and one mixed insulinoma–glucagonoma were higher than that of normal control pancreases. A study of protein meal‐stimulated PP secretion revealed that three of the insulinoma cases and two gastrinoma cases exhibited higher plasma PP levels than the age‐matched controls. The findings suggest that: (1) both functioning and nonfunctioning islet cell tumors derive from neuroendocrine cells positive for NSE; (2) all functioning islet cell tumors appear to contain PP in the tumor tissue as a minor component; (3) as many as 70% of the patients with islet cell tumors present with abnormally higher plasma PP levels after protein meals; and (4) a study of meal‐stimulated PP secretion may well be used as a marker for the presence of functional islet cell tumors. Cancer 56: 1649‐1657, 1985.